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ABSTRACT
Introductions: Breast lump is mostly benign in nature however carcinoma of 
the breast also presents as a simple lump. Since breast carcinoma is the second 
most common killer of the female cancer it is important to detect it at early 
stage and treat. The purpose of the study was to analyse histopathology profile 
of breast lump.
Methods: Histopathology samples were received, processed, reported and 
recorded in the Pathology laboratory of Helping Hands Community Hospital, 
Kathmandu. Data analysed from 2008 to 2011. Descriptive statistics was used 
to analyse the data. 
Results: Out of 1991 histopathology samples 68 were breast lumps. Fifty 
(73.5%) were benign and 18 (26.5%) were malignant. Ten (55.5%) of carcinoma 
was seen in between 41 and 50 years. Eleven (46%) of the malignant neoplasm 
were of Stage IIIA.
Conclusions: Every fourth sample had carcinoma and it is mostly seen after 40 
years of age.
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Plain Language Summary 
The study was done to see the histopathological profile of breast lump. The study 
found that majority of the patients was diagnosed with benign lump. Even though 
the breast cancer is the second most common killer of female cancer the most 
common lesions in the breast are benign in nature. 
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INTRODUCTIONS
The mammogram, which is the screening test done for 
breast lumps is not easily available and due to its high 
cost many patients cannot afford it. Histopathological 
study of biopsy specimen is one of the easiest and 
cheapest forms of diagnostic method which is 
affordable, available to give tissue diagnosis. Tissue 
diagnosis is considered as the minimum requirement 
to start specific treatment in breast lump.
Both incidence and mortality from breast cancer has 
increased by 14% and 20% respectively since 2008; 
and the incidence is even more in developing countries 
increasing by 5% per year.1,2 So, this study was done to 
find out the histopathological characteristics of breast 
lump. 
METHODS
This is a cross sectional study of breast biopsy specimen 
received from 2008 to 2011 at the Department of 
Pathology, Helping Hands Community Hospital, 
Kathmandu, Nepal. The specimens were labelled, 
entered in the data system of the lab and kept for 
fixation in 10% Formalin overnight. After grossing, it was 
processed in the tissue processor, making blocks and 
cut into sections of 0.4 micron thickness. After staining 
with hematoxyllin and eosin, slides were examined 
by pathologists.  All the findings were recorded in the 
database. 
RESULTS
Out of 1991 specimens received, 68 (3.4%) cases were of 
breast pathology. The benign and malignant conditions 
were 50 and 18 respectively.  The histopathological 
types of breast lumps are presented in Table 2.  
Table 1. Age group wise distribution of breast lump 
pathology
Age group Benign Malignant Total
<20 3 0 3
21-30 23 1 24
31-40 13 1 14
41-50 6 10 16
51-60 4 2 6
61-70 1 1 2
>70 0 3 3






Benign Breast Aspirate 7 10.3
Duct ectasia 2 2.9
Parasitic 2 2.9
Fibroadenosis 1 1.5
Granulomatous mastitis 1 1.5
Galactocele 1 1.5
Total 68 100.0
All malignant tumors were infiltrating ductal carcinoma 
(not otherwise specified, NOS) at different stages. 
Out of 18 malignancies, 11 were Modified Radical 
Mastectomy (MRM) specimen. Size of tumor ranged 
from 2x2.5 to 8x3.5 cm. Nipple, quadrants and the 
deep margins were clear of tumor cells in all MRM. 
Lymph nodes were identified in all MRM specimens and 
were positive for tumor cell in eight cases. Maximum 
numbers of lymph nodes seen in the MRM specimen 
were 11. Out of 11 MRM specimens three were in stage 
IIA, three in stage IIB and five were of stage IIIA.
DISCUSSIONS
In this study benign breast disease (BBD) was common 
presentation in 50 cases (73.5%). This finding is similar 
to the study done by Khan S in Nepalgunj Medical 
College where the BBD was seen in 93.2% of the cases.3 
The most common benign lesion was fibroadenoma 
(41.2%), comparable to the study by Giri R, et al where 
fibroadenoma was seen in 32%.4 Fibroadenoma was 
seen in third and fourth decade of life, similar to other 
studies.3-5 Six fibroadenoma showed myxoid changes 
and all were in age group of 21-30 years, except one in 
36 years of age. Duct ectasia was seen in two in the age 
group 31-40 years which is similar to Pradhan M.6 Duct 
ectasia can mimic carcinoma of the breast because of 
the signs of nipple retraction, inversion, pain and bloody 
discharge. All the pathology is due to the obstruction of 
the lactiferous duct. In this study benign breast aspirate 
was seen in seven (10.29%) which correlates with the 
study done in Bharatpur cancer hospital where the 
result for normal breast aspirate was 10.64%.6 There 
were cases of parasitic infiltration, one each of hydatid 
cyst and cysticercosis. Agnihotri S has reported a case 
of cysticercosis in the breast lump at Manipal Hospital, 
Nepal.7
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Breast cancer is the second common cancer in women 
after cervical cancer.8 Because of the social taboos and 
less education women in Nepal tend to seek medical 
help at later stage. Ignorance of self breast examination 
and lack of promotional education by the health care 
professionals in communities may be the reason for 
late presentation of the breast diseases.4 Breast cancer 
is on the rise in Nepal as evidenced by various studies 
done in the last few decades.9,10 All cases of malignant 
neoplasm (26.5%) were infiltrating ductal carcinoma 
NOS, similar  to Sharma A.11 Out of the 18 malignant 
neoplasm, 10 (55.55%) were in the age group 41-50 
years, six in patients above the age of 51 and only 
two cases below the age of 40 years. In a study done 
in Bhaktapur Cancer Hospital, Nepal, the mean age of 
patients presenting with breast cancer was 49.4 years.11 
Similarly, Nielsen M, et al found maximum number 
of patients (39%) with malignancy were in the age 
group 40-49 years,12 and another study in a hospital in 
Kathmandu.13 Out of all specimens 11 were of Modified 
Radical Mastectomy (MRM).   Data from ‘Surveillance, 
Epidemiology, and End Results (SEER) Program’ USA 
shows as tumor size increases, breast cancer survival 
decreases.  For tumor less than one cm in size, five year 
relative breast cancer survival is 93% and for larger than 
five cm only 63%.14 In our study the tumor size ranged 
from two cm to more than five cm. Lymph nodes were 
identified in all cases of MRM specimens however it 
was positive for tumor cells in only eight cases. Each 
positive lymph node increases the additional risk of 
cancer death by approximately 6%.15
Almost half (46%) of the MRM specimens were of 
stage IIIA. Due to lack of proper screening about 75% 
of women with breast cancer in developing countries 
are diagnosed in clinical stages III and IV, whereas 
approximately 70% of newly diagnosed women with 
breast cancer in North America are in stages 0 and 1.16
CONCLUSIONS
In this study, 3/4th breast lumps were benign. All 
malignant lesions were adenocarcinoma, commonly 
seen after 40 years of age, and advanced stage with 
nearly half of mastectomy specimens in stage IIIA.
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